{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:38:41Z","timestamp":1793047121984,"version":"4.5.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Cytomegalovirus (CMV) infection is a risk factor for chronic lung allograft dysfunction (CLAD), which limits survival in lung allograft recipients. Natural killer (NK) cells that express the NKG2C receptor mediate CMV-specific immune responses. We hypothesized that NKG2C<jats:sup>+<\/jats:sup> NK cells responding to CMV in the lung allograft would reduce CMV-related inflammation and would improve CLAD-free survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We prospectively followed 130 subjects who underwent lung transplantation from 2012 to 2016. Bronchoalveolar lavage (BAL) NK cells were immunophenotyped for NKG2C, maturation, and proliferation markers. CMV viral load, serologies, serial spirometry, and mortality were recorded from medical records. Natural killer cell subset association with CMV endpoints were made using generalized estimating equation-adjusted linear models. BAL NKG2C<jats:sup>+<\/jats:sup> NK cell association with CLAD-free survival was assessed by Cox proportional hazards modeling.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>NKG2C<jats:sup>+<\/jats:sup> NK cells were more mature and proliferative than NKG2C<jats:sup>\u2212<\/jats:sup> NK cells and represented a median of 7.8% of BAL NK cells. The NKG2C<jats:sup>+<\/jats:sup> NK cell proportion increased prior to the first detection of viremia and was nearly tripled in subjects with high level viremia (&gt;1000 copies\/mL) compared with no detected viremia. Subjects with increased BAL NKG2C<jats:sup>+<\/jats:sup> NK cells, relative to the median, had a significantly increased risk for CLAD or death (hazard ratio, 4.2; 95% confidence interval, 1.2\u201313.3).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>The BAL NKG2C<jats:sup>+<\/jats:sup> NK cell proportion may be a relevant biomarker for assessing risk of CMV viremia and quantifying potential CMV-related graft injury that can lead to CLAD or death.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002450","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T07:06:42Z","timestamp":1538204802000},"page":"493-501","source":"Crossref","is-referenced-by-count":42,"title":["NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients"],"prefix":"10.1097","volume":"103","author":[{"given":"Daniel R.","family":"Calabrese","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Singer","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gottschall","sequence":"additional","affiliation":[{"name":"Department of Clinical Lab Immunology, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Hays","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Golden","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasleen","family":"Kukreja","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis L.","family":"Lanier","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and the Parker Institute for Cancer Immunotherapy, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.healun.2014.08.004","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report\u20142014; focus theme: retransplantation.","volume":"33","author":"Yusen","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.21037\/jtd.2017.07.81","article-title":"Chronic lung allograft dysfunction phenotypes and treatment.","volume":"9","author":"Verleden","year":"2017","journal-title":"J Thorac Dis"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome.","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1600-6143.2011.03663.x","article-title":"Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome.","volume":"11","author":"Paraskeva","year":"2011","journal-title":"Am J Transplant"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.trre.2014.01.001","article-title":"The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.","volume":"28","author":"Roman","year":"2014","journal-title":"Transplant Rev"},{"issue":"19 Supp 5","key":"R6-20231002","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2146\/ajhp060377","article-title":"Etiology and impact of cytomegalovirus disease on solid organ transplant recipients.","volume":"63","author":"McDevitt","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"R7-20231002","first-page":"e12877","article-title":"Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the organ transplant infection prevention and detection study: a multi-year, multicenter prospective cohort study.","volume":"2018","author":"Avery","journal-title":"Transpl Infect Dis"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/cix259","article-title":"Risk factors and outcomes of ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients.","volume":"65","author":"Fisher","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R9-20231002","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.","volume":"2008","author":"Hodson","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.eimc.2011.05.022","article-title":"GESITRA-SEIMC\/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.","volume":"29","author":"de la Torre-Cisneros","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1128\/CVI.00214-09","article-title":"Age-dependent association between low frequency of CD27\/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.","volume":"16","author":"Cantisan","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1111\/j.1600-6143.2009.02824.x","article-title":"The \u2018indirect\u2019 effects of cytomegalovirus infection.","volume":"9","author":"Freeman","year":"2009","journal-title":"Am J Transplant"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.coi.2007.07.012","article-title":"Acceleration of allograft failure by cytomegalovirus.","volume":"19","author":"Streblow","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MOT.0b013e32834254cf","article-title":"Natural killer cells in rejection and tolerance of solid organ allografts.","volume":"16","author":"Benichou","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"R15-20231002","article-title":"Natural killer cells in lung transplantation.","author":"Calabrese","journal-title":"Thorax"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1097\/TP.0000000000001592","article-title":"BOS is associated with increased cytotoxic proinflammatory CD8 T, NKT-like, and NK cells in the small airways.","volume":"101","author":"Hodge","year":"2017","journal-title":"Transplantation"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fimmu.2016.00235","article-title":"\u201cnatural regulators\u201d: NK cells as modulators of T cell immunity.","volume":"7","author":"Schuster","year":"2016","journal-title":"Front Immunol"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","article-title":"NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.","volume":"10","author":"Hidalgo","year":"2010","journal-title":"Am J Transplant"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/ajt.14295","article-title":"HLA mismatching favoring host-versus-graft NK cell activity via KIR3DL1 is associated with improved outcomes following lung transplantation.","volume":"17","author":"Greenland","year":"2017","journal-title":"Am J Transplant"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/ajt.14257","article-title":"Cytotoxicity of natural killer cells activated through NKG2D contributes to the development of bronchiolitis obliterans in a murine heterotopic tracheal transplant model.","volume":"17","author":"Kawakami","year":"2017","journal-title":"Am J Transplant"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ajt.12630","article-title":"Bronchoalveolar lavage cell immunophenotyping facilitates diagnosis of lung allograft rejection.","volume":"14","author":"Greenland","year":"2014","journal-title":"Am J Transplant"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/TP.0000000000000757","article-title":"The role of natural killer cells in humoral rejection.","volume":"99","author":"Resch","year":"2015","journal-title":"Transplantation"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/imm.12921","article-title":"Natural killer cell cytotoxicity and its regulation by inhibitory receptors.","volume":"154","author":"Kumar","year":"2018","journal-title":"Immunology"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3389\/fimmu.2017.01556","article-title":"Gradual increase of Fc\u03b3RIIIa\/CD16a expression and shift toward IFN-\u03b3 secretion during differentiation of CD56dim natural killer cells.","volume":"8","author":"Lajoie","year":"2017","journal-title":"Front Immunol"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.20091193","article-title":"Innate immunity defines the capacity of antiviral T cells to limit persistent infection.","volume":"207","author":"Andrews","year":"2010","journal-title":"J Exp Med"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/1521-4141(2001010)31:10<3048::AID-IMMU3048>3.0.CO;2-1","article-title":"NK cell functions restrain T cell responses during viral infections.","volume":"31","author":"Su","year":"2001","journal-title":"Eur J Immunol"},{"key":"R28-20231002","first-page":"A3252","article-title":"Natural killer cell maturation is associated with acute infection in lung transplant recipients.","volume":"2017","author":"Calabrese","journal-title":"AJRCCM: Translational Studies in Lung Transplantation"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.","volume":"108","author":"Lopez-Verges","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.4049\/jimmunol.1303211","article-title":"Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.","volume":"192","author":"Hendricks","year":"2014","journal-title":"J Immunol"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/infdis\/jix608","article-title":"Puchhammer-Stockl E. NKG2C deletion is a risk factor for human cytomegalovirus viremia and disease after lung transplantation.","volume":"217","author":"Vietzen","year":"2018","journal-title":"J Infect Dis"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/eji.201546179","article-title":"Coordinated expansion of both memory T cells and NK cells in response to CMV infection in humans.","volume":"46","author":"Bayard","year":"2016","journal-title":"Eur J Immunol"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.healun.2013.10.022","article-title":"A new classification system for chronic lung allograft dysfunction.","volume":"33","author":"Verleden","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R35-20231002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.201206-1025OC","article-title":"Association of large-airway lymphocytic bronchitis with bronchiolitis obliterans syndrome.","volume":"187","author":"Greenland","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 3","key":"R37-20231002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001094","article-title":"Cytomegalovirus immunoglobulin after thoracic transplantation: an overview.","volume":"100","author":"Grossi","year":"2016","journal-title":"Transplantation"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1399-3062.2012.00723.x","article-title":"Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis.","volume":"14","author":"Wiita","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"R39-20231002","doi-asserted-by":"crossref","first-page":"ofv212","DOI":"10.1093\/ofid\/ofv212","article-title":"Molecular and culture-based bronchoalveolar lavage fluid testing for the diagnosis of cytomegalovirus pneumonitis.","volume":"3","author":"Tan","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"R40-20231002","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/TP.0000000000001338","article-title":"Recurrence of CMV infection and the effect of prolonged antivirals in organ transplant recipients.","volume":"101","author":"Natori","year":"2017","journal-title":"Transplantation"},{"key":"R41-20231002","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1097\/TP.0000000000001191","article-title":"Donor-reactive regulatory T cell frequency increases during acute cellular rejection of lung allografts.","volume":"100","author":"Greenland","year":"2016","journal-title":"Transplantation"},{"key":"R42-20231002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.trim.2014.08.002","article-title":"Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation.","volume":"31","author":"de Rham","year":"2014","journal-title":"Transpl Immunol"},{"key":"R43-20231002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4049\/jimmunol.1601236","article-title":"Adaptive NKG2C+ NK cell response and the risk of cytomegalovirus infection in kidney transplant recipients.","volume":"198","author":"Redondo-Pachon","year":"2017","journal-title":"J Immunol"},{"key":"R44-20231002","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1053-2498(02)00471-0","article-title":"Cytomegalovirus antibody status of donor\/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.","volume":"22","author":"Luckraz","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R45-20231002","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1097\/TP.0000000000000549","article-title":"Incidence, risk factors and outcomes of delayed-onset cytomegalovirus disease in a large retrospective cohort of lung transplant recipients.","volume":"99","author":"Santos","year":"2015","journal-title":"Transplantation"},{"key":"R46-20231002","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCULATIONAHA.105.607549","article-title":"T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.","volume":"114","author":"Tu","year":"2006","journal-title":"Circulation"},{"key":"R47-20231002","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/TP.0000000000001927","article-title":"Cytomegalovirus viral load in bronchoalveolar lavage to diagnose lung transplant associated CMV pneumonia.","volume":"102","author":"Lodding","year":"2018","journal-title":"Transplantation"},{"key":"R48-20231002","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway.","volume":"9","author":"Viel","year":"2016","journal-title":"Sci Signal"},{"key":"R49-20231002","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"R50-20231002","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1600-6143.2011.03837.x","article-title":"Is prevention the best treatment? CMV after lung transplantation.","volume":"12","author":"Patel","year":"2012","journal-title":"Am J Transplant"},{"key":"R51-20231002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.20100762","article-title":"Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.","volume":"208","author":"Bjorkstrom","year":"2011","journal-title":"J Exp Med"},{"key":"R52-20231002","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fimmu.2018.00474","article-title":"Adaptive reconfiguration of natural killer cells in HIV-1 infection.","volume":"9","author":"Peppa","year":"2018","journal-title":"Front Immunol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201903000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:26:16Z","timestamp":1696224376000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201903000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002450","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}